Brodalumab: 5-Year US Pharmacovigilance Report

Brodalumab: 5-Year US Pharmacovigilance Report

Abstract Introduction Brodalumab is a human interleukin-17 receptor A antagonist indicated for the treatment of moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic therapies....

Full description

Saved in:
Bibliographic Details
Main Authors: Mark G. Lebwohl (Author), John Y. Koo (Author), April W. Armstrong (Author), Bruce E. Strober (Author), George M. Martin (Author), Nicole N. Rawnsley (Author), Earl L. Goehring (Author), Abby A. Jacobson (Author)
Format: Book
Published: Adis, Springer Healthcare, 2024-05-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items